[Enzyme preparations in conservative treatment of chronic pancreatitis].
OBJECTIVE
To study effectiveness of enzyme medicine pancitrate 25,000 in the treatment of chronic pancreatitis (CP).


METHODS
Pain, stool, creato- and steatorea, other signs of CP were examined before and after pancitrate treatment of 17 patients with chronic pancreatitis aged from 28 to 62 years.


RESULTS
Pancitrate 25,000 reduced stomach pains in 16 of 17 patients. Stool returned to normal in 8 of 13 patients. Creato- and steatorea decreased.


CONCLUSIONS
New dosage forms of the enzyme preparations (pancitrate 25,000, in particular) are highly effective both in deficiency of pancreatic external secretion and pain relief in exacerbation of CP.
Okhlobystin
A V
AV
Bayarmaa
N
N
D015746:Abdominal Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000328:Adult; D000681:Amylases / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D002446:Celiac Disease / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D002908:Chronic Disease; D004333:Drug Administration Routes; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008049:Lipase / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D012189:Retrospective Studies; D016896:Treatment Outcome; D014357:Trypsin / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D005765:Gastrointestinal Agents; D008049:Lipase; D000681:Amylases; D014357:Trypsin
Fermentnye preparaty pri konservativnom lechenii khronicheskogo pankreatita.